Procept BioRobotics Corp [PRCT] stock is trading at $27.93, down -1.65%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PRCT shares have lost -9.23% over the last week, with a monthly amount drifted -19.30%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on September 02, 2025, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $60 for it. Previously, Stephens started tracking the stock with Overweight rating on July 09, 2025, and set its price target to $70. On July 07, 2025, Oppenheimer initiated with a Perform rating. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $105 on December 02, 2024. Jefferies initiated its recommendation with a Hold and recommended $95 as its price target on November 14, 2024. Piper Sandler started tracking with a Overweight rating for this stock on August 11, 2023, and assigned it a price target of $42. In a note dated May 31, 2023, William Blair initiated an Outperform rating.
Procept BioRobotics Corp [PRCT] stock has fluctuated between $28.28 and $100.89 over the past year. Currently, Wall Street analysts expect the stock to reach $53.2 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $27.93 at the most recent close of the market. An investor can expect a potential return of 90.48% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
Procept BioRobotics Corp [NASDAQ:PRCT] reported sales of 299.91M for the trailing twelve months, which represents a growth of 42.76%. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.28%, and Net Profit Margin reading is -0.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.22 and Total Capital is -0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.67 points at the first support level, and at 27.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.37, and for the 2nd resistance point, it is at 28.80.
Ratios To Look Out For
For context, Procept BioRobotics Corp’s Current Ratio is 8.43. Also, the Quick Ratio is 7.19, while the Cash Ratio stands at 5.46. Considering the valuation of this stock, the price to sales ratio is 5.20, the price to book ratio is 4.10.
Transactions by insiders
Recent insider trading involved MOLL FREDERIC H, Director, that happened on Aug 13 ’25 when 20000.0 shares were purchased. Director, Desai Antal Rohit completed a deal on Jun 10 ’25 to sell 25000.0 shares. Meanwhile, Director Desai Antal Rohit sold 25000.0 shares on Jun 11 ’25.
